Team Penn Medicine
Welcome to Team Penn Medicine!
Thank you for joining Team Penn Medicine in support of the 25th Annual Gift of Life Donor Dash on April 19, 2020.
The Dash celebrates the life-saving power of donation and honors all of the donors who make it possible. By supporting Gift of Life and the Donor Dash, you will help raise awareness about the critical need to increase the number of those registered as organ and tissue donors.
Thank you so much for all of your support, and we look forward to seeing you at the Donor Dash!
Team Penn Medicine
The Penn Transplant Institute
Penn Transplant Institute
A Lifetime Transformed by Transplant
Penn Transplant Institute offers a life-long care approach and a specialized, dedicated team that will support you every step of the way, and for your whole life after transplant.
Our physicians, nurses, counselors and surgeons work with patients and their families to determine eligibility for transplantation, and follow them through post-op care to ensure the transplanted organ is functioning properly. We have been a pioneer in organ transplantation for more than 50 years. In 2013, we became the fourteenth institution in the country and the first in the region to perform 5,000 kidney transplants.
The Penn Transplant Institute consistently meets or exceeds the national average in all organ transplants. These superior outcomes are a result of the combined efforts of multiple clinical departments across Penn Medicine and a unique, multidisciplinary approach to the treatment of end-stage organ disease.
To learn more:
The birth of Benjamin Thomas Gobrecht defied both expectation and imagination: his mother, 33-year-old Jennifer Gobrecht, was born without a uterus. Benjamin, who arrived in November 2019 at the Hospital of the University of Pennsylvania, grew inside a womb Jennifer received as part of an organ transplant research trial over a year earlier. Benjamin is the first baby born as part of Penn Medicine’s Uterus Transplantation for Uterine Factor Infertility (UNTIL) trial, which launched in 2017. He is the second baby in the nation to be born following transplantation of a uterus from a deceased donor.
Jen was born with a congenital condition called Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, which means she has functional ovaries but does not have a fully formed uterus. MRKH affects approximately 1 out of every 4,500 females, and makes it impossible for women to get pregnant or carry a child. It’s one example of Uterine Factor Infertility (UFI), which is a previously irreversible form of female infertility that affects as many as five percent of reproductive-aged women worldwide. A person with UFI cannot carry a pregnancy either because she was born without a uterus, has had the organ surgically removed, or has a uterus that does not function properly.
The uterus transplantation done as part of this clinical trial is a complex investigational procedure that involves both surgical and medical management. More than 35 health care providers and clinical investigators are involved in each trial participant’s care over the course of a five- to 10-year research period, which spans IVF, transplantation and birth, to long term follow-up after delivery and after the surgical removal of the organ after delivery.